Aspen Pharmacare
(OTC) APNHY
Aspen Pharmacare Financials at a Glance
Market Cap
$3.94B
Revenue (TTM)
ZAR 83.20B
Net Income (TTM)
ZAR 2.41B
EPS (TTM)
-$0.23
P/E Ratio
-37.79
Dividend
$0.12
Beta (Volatility)
0.33 (Low)
Dividend
$0.12
Beta (Volatility)
0.33 (Low)
Price
$8.87
Volume
4
Open
$8.87
Price
$8.87
Volume
4
Open
$8.87
Previous Close
$8.87
Daily Range
$8.87 - $8.87
52-Week Range
$5.24 - $8.87
Estimated Earnings Date
Sep 2, 2026
Dividend
$0.12
Beta (Volatility)
0.33 (Low)
Price
$8.87
Volume
4
Open
$8.87
Previous Close
$8.87
Daily Range
$8.87 - $8.87
52-Week Range
$5.24 - $8.87
Estimated Earnings Date
Sep 2, 2026
APNHY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aspen Pharmacare
Industry
Pharmaceuticals
Sector
Health CareEmployees
9,557
CEO
Stephen Bradley Saad, PhD
Website
www.aspenpharma.comHeadquarters
Durban, ZA
APNHY Financials
Key Financial Metrics (TTM)
Gross Margin
42%
Operating Margin
16%
Net Income Margin
-5%
Return on Equity
-3%
Return on Capital
5%
Return on Assets
-2%
Earnings Yield
-2.65%
Dividend Yield
1.38%
Payout Ratio
-47.07%
Stock Overview
Market Cap
$3.94B
Shares Outstanding
444.02M
Volume
4
Avg. Volume
213.031
Financials (TTM)
Gross Profit
ZAR 19.13B
Operating Income
ZAR 1.44B
EBITDA
ZAR 2.16B
Operating Cash Flow
ZAR 5.16B
Capital Expenditure
-ZAR 5.06B
Free Cash Flow
ZAR 104.00M
Cash & ST Invst.
ZAR 6.41B
Total Debt
ZAR 36.12B
Aspen Pharmacare Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
ZAR 16.27B
-23.0%
Gross Profit
ZAR 7.10B
-23.8%
Gross Margin
43.64%
N/A
Market Cap
$3.94B
N/A
Market Cap/Employee
$443.92K
N/A
Employees
8,867
N/A
Net Income
ZAR 1.40B
-39.4%
EBITDA
ZAR 3.87B
-12.9%
Quarterly Fundamentals
Net Cash
-ZAR 27.30B
-11.3%
Accounts Receivable
ZAR 10.07B
+1010.1%
Inventory
ZAR 15.44B
-18.5%
Long Term Debt
ZAR 29.31B
+19.5%
Short Term Debt
ZAR 3.60B
-68.9%
Return on Assets
-1.56%
N/A
Return on Invested Capital
5.49%
N/A
Free Cash Flow
ZAR 2.33B
+141.5%
Operating Cash Flow
ZAR 3.41B
+38.6%